Lipid-Polymer Hybrid Nanoparticles (LPHNPs) for RNA Delivery.

Area of Science:

• Biomaterials Science
• Nanotechnology
• Molecular Biology

Background:

• RNA therapeutics show great promise but require effective delivery systems.
• Current lipid nanoparticles (LNPs) face limitations in stability, targeting, and responsiveness.
• New nanoparticle platforms are crucial for advancing RNA-based medicine.

Purpose of the Study:

• To develop and review novel lipid-polymer hybrid nanoparticles (LPHNPs) for enhanced RNA delivery.
• To showcase the design, synthesis, and applications of LPHNPs in diverse biomedical contexts.
• To provide a roadmap for next-generation RNA delivery platforms.

Main Methods:

• Design and synthesis of LPHNPs using biodegradable polymers like PLGA, HA, and Cys-PDSA.
• Incorporation of tailored polymer properties for structural stability, targeted delivery, and controlled release.
• Evaluation of LPHNP performance metrics: colloidal stability, RNA loading, cellular uptake, endosomal escape, and targeting efficacy.

Main Results:

• LPHNPs demonstrate tunable architectures for efficient RNA encapsulation and site-specific delivery.
• Successful application of LPHNPs across various administration routes (oral, inhaled, IV, intravesical).
• Therapeutic efficacy shown in models of cancer, inflammatory diseases, and respiratory conditions.

Conclusions:

• LPHNPs offer a versatile and modular platform for next-generation RNA therapeutics.
• These advanced delivery systems overcome key barriers, enabling precise RNA delivery.
• LPHNP technology holds significant translational potential for a broad spectrum of diseases.